BriaCell Therapeutics (BCTXW) News Today $0.10 -0.01 (-4.77%) As of 10:00 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Decreases By 58.3%March 27, 2025 | americanbankingnews.comSecond Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast CancerMarch 20, 2025 | markets.businessinsider.comBriaCell Therapeutics Reports Continued Financial ChallengesMarch 12, 2025 | tipranks.comBriaCell regains Nasdaq compliance with bid priceFebruary 13, 2025 | msn.comBriaCell Therapeutics Corp. Announces Results of Shareholder MeetingFebruary 5, 2025 | financialpost.comBriaCell Completes 15:1 Share Consolidation for Nasdaq ComplianceJanuary 27, 2025 | tipranks.comBriaCell Therapeutics Corp.: BriaCell Announces Proposed Effective Date of Share ConsolidationJanuary 5, 2025 | finanznachrichten.deBriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast CancerDecember 13, 2024 | finance.yahoo.comBriaCell Therapeutics Faces Uncertain Financial FutureNovember 2, 2024 | markets.businessinsider.comBriaCell Quadruples Progression Free Survival (PFS) in Patient with "Eye-Bulging" Metastatic Breast CancerJuly 21, 2024 | stockhouse.comBriaCell reports extended survival in breast cancer studyJuly 21, 2024 | investing.comBriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS First in Human StudyMay 28, 2024 | finance.yahoo.comBriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS(TM) First in Human StudyMay 28, 2024 | stockhouse.comBriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human StudyMay 28, 2024 | finance.yahoo.comThis BriaCell Therapeutics Insider Increased Their Holding By 55% Last YearMay 24, 2024 | finance.yahoo.comBriacell Therapeutics Corp (BCTX)May 16, 2024 | uk.investing.comGet Rich Quick With These 3 Penny Stocks to Buy NowFebruary 20, 2024 | finance.yahoo.comBriaCell Therapeutics Corp.: BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder CaseFebruary 7, 2024 | finanznachrichten.deBreaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP ManufacturingFebruary 6, 2024 | finance.yahoo.comBriaCell Therapeutics: Bottom 25 Performing Stocks Year-to-Date on TSX (BCT)January 6, 2024 | theglobeandmail.comBriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast CancerJanuary 4, 2024 | finance.yahoo.comBriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical BenefitDecember 6, 2023 | finance.yahoo.comBriaCell Therapeutics Corp.: BriaCell Records New Responder with Remarkable Improvement of "Eye-Bulging" Metastatic TumorNovember 30, 2023 | finanznachrichten.deBriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic TumorNovember 30, 2023 | finance.yahoo.comBriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) ConferencesOctober 18, 2023 | finance.yahoo.comBriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT™ in Advanced Breast CancerOctober 4, 2023 | finance.yahoo.comBriaCell Receives Court Approval for the Share Arrangement Spinning Out BriaPro Therapeutics (SpinCo) to Existing ShareholdersAugust 25, 2023 | finance.yahoo.comBriaCell Enters Definitive Arrangement Agreement for the Spin Out of BriaPro Therapeutics Corp.May 25, 2023 | finance.yahoo.comBriaCell Presents Positive Data Demonstrating Survival and Clinical Benefits in Advanced Metastatic Breast Cancer at the 2023 AACRApril 17, 2023 | finance.yahoo.comBriaCell intends to launch a spinoff to accelerate its drug development activitiesApril 3, 2023 | bizjournals.comBriaCell to Present Clinical and Survival Data in Advanced Metastatic Breast Cancer at the 2023 AACR Annual MeetingMarch 15, 2023 | finance.yahoo.comBriaCell Therapeutics Corp.: BriaCell to Investigate Alleged Illegal Trading of Public SecuritiesJanuary 23, 2023 | finanznachrichten.deBriaCell Announces New Patent Issuance, Bria-OTS™ IND Timing Guidance, and Additional Clinical Sites to Boost EnrolmentJanuary 10, 2023 | finance.yahoo.comBriaCell Announces Positive Clinical and Quality of Life Data in Advanced Metastatic Breast Cancer at 2022 San Antonio Breast Cancer Symposium®December 8, 2022 | finance.yahoo.comBriaCell Announces Successful Completion of Phase I Portion of Clinical Study in Advanced Breast Cancer; Randomized Phase II Efficacy Evaluation ProgressingOctober 21, 2022 | finance.yahoo.comBriaCell Secures License for a Promising Novel Anti-Cancer AgentAugust 4, 2022 | finance.yahoo.comBriaCell Enters Research Agreement to Identify Novel Targets for Cancer TreatmentJune 29, 2022 | finance.yahoo.com Remove Ads Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXW and its competitors with MarketBeat's FREE daily newsletter. Email Address BCTXW Media Mentions By Week BCTXW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCTXW News Sentiment▼1.280.82▲Average Medical News Sentiment BCTXW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCTXW Articles This Week▼30▲BCTXW Articles Average Week Remove Ads Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Clever Leaves News Today enGene News Today Fortress Biotech News Today GeoVax Labs News Today Lexaria Bioscience News Today NexImmune News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCTXW) was last updated on 3/31/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCTXW Stock Free BCTXW Stock Alerts